Stocks / STE
STE stock forecast
STERIS PLC · Healthcare · Medical Devices
Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.
STE is not among the 20 largest holdings published for 2026 Q4. See the portfolio
STE against the S&P 500
| Period | STE | S&P 500 (SPY) |
|---|---|---|
| 1 month | +17.3% | -4.7% |
| 3 months | +10.2% | -4.8% |
| Year to date | +3.6% | +7.9% |
| 1 year | +2.1% | +11.8% |
Total return, dividends included.
Key numbers
| Price | $259.57 |
| Market cap | 25.21 Billion |
| P/E (trailing 12 months) | 30.7 |
| P/S (trailing 12 months) | 4.1 |
| P/B (latest quarter) | 3.4 |
| Gross margin | 44.6% |
| Net profit margin | 13.4% |
| Return on equity | 11.5% |
| Beta | 0.4 |
As of November 5, 2026.
STE and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| DXCM | DEXCOM INC | 30.78 Billion | Outperform | DXCM vs STE |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 19.55 Billion | Underperform | STE vs ZBH |
| ALGN | ALIGN TECHNOLOGY INC | 11.56 Billion | Outperform | STE vs ALGN |
| PODD | INSULET CORP | 9.71 Billion | Outperform | STE vs PODD |
| EW | EDWARDS LIFESCIENCES CORP | 60.51 Billion | Underperform | EW vs STE |
| BSX | BOSTON SCIENTIFIC CORP | 63.26 Billion | Greatly Outperform | BSX vs STE |
Questions
What does the Upfront Investment model say about STE?
The model rates STERIS PLC (STE) "Greatly Underperform" as of November 18, 2026, which means its medium-term return forecast is in the bottom fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the STE rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is STE in the Upfront Investment model portfolio?
STE is not among the 20 largest holdings published for 2026 Q4.
The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.